---
figid: PMC7915189__cancers-13-00683-g002
figtitle: Some examples of signaling pathways involved in OS resistant tumor cells
  to conventional treatment
organisms:
- Mus musculus
- Cricetulus griseus
- Cricetus cricetus
- Homo sapiens
- Canis lupus familiaris
pmcid: PMC7915189
filename: cancers-13-00683-g002.jpg
figlink: pmc/articles/PMC7915189/figure/cancers-13-00683-f002/
number: F2
caption: Some examples of signaling pathways involved in OS resistant tumor cells
  to conventional treatment. Cell surface-receptors, such as tyrosine kinase receptors
  (RTKs), are disturbed in resistant cells to chemotherapy. Over-expression and phosphorylation
  of RTKs activate signaling pathways such as mitogen-activated protein kinases (MAPK)
  or phosphoinositol 3-kinase (PI3K)-protein kinase signaling pathway. Activation
  of MAPK and/or PI3K leads to proliferation and survival, respectively. Several WNT
  ligands (WNT 10b) and receptors (lipoprotein receptor-related protein 5—LRP5) and
  β-catenin are over-expressed and activate the WNT/β-catenin pathway leading to β-catenin
  overexpression. β-catenin is able to repress syndecan-2 leading to inhibition of
  apoptosis and chemosensitivity.
papertitle: Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
reftext: Louise Marchandet, et al. Cancers (Basel). 2021 Feb;13(4):683.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9523671
figid_alias: PMC7915189__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Cricetulus griseus
- Canis lupus familiaris
redirect_from: /figures/PMC7915189__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7915189__cancers-13-00683-g002.html
  '@type': Dataset
  description: Some examples of signaling pathways involved in OS resistant tumor
    cells to conventional treatment. Cell surface-receptors, such as tyrosine kinase
    receptors (RTKs), are disturbed in resistant cells to chemotherapy. Over-expression
    and phosphorylation of RTKs activate signaling pathways such as mitogen-activated
    protein kinases (MAPK) or phosphoinositol 3-kinase (PI3K)-protein kinase signaling
    pathway. Activation of MAPK and/or PI3K leads to proliferation and survival, respectively.
    Several WNT ligands (WNT 10b) and receptors (lipoprotein receptor-related protein
    5—LRP5) and β-catenin are over-expressed and activate the WNT/β-catenin pathway
    leading to β-catenin overexpression. β-catenin is able to repress syndecan-2 leading
    to inhibition of apoptosis and chemosensitivity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LPRS6
  - LPRS
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3B
  - AXIN1
  - AXIN2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CTNNB1
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - Dvl1
  - Gsk3b
  - Axin1
  - Cdkn1a
  - Cdkn1c
  - Pik3r1
  - Ctnnb1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pten
  - Akt1
  - Sdc2
  - Zhx2
  - Mtor
  - Mdk
  - Ephb2
  - Mapk1
---
